Insider transactions

EDGAR

ENVISTA HOLDINGS CORPORATION

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-16.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
3 transactions, 17,675 shares
Sum of shares × price per share: 510,250

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 60

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-01 Filed 2026-11-02Keel Paul A Director · Officer: Chairman and CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)54,19723.51
1,274,171.47

Derived: shares × price per share. Exact value 1274171.47.

497,107Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Open filing 0001626337-26-000013 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-27Nilsson Stefan Officer: President, Nobel Biocare
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)80427.47
22,085.88

Derived: shares × price per share. Exact value 22085.88.

61,560Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Open filing 0002045818-26-000005 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-27Befidi Robert Officer: President, Diagnostics
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,14727.47
141,388.09

Derived: shares × price per share. Exact value 141388.09.

45,785Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Open filing 0002012361-26-000007 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-27Acurio Veronica Officer: President, Orthodontics
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)7,71027.47
211,793.7

Derived: shares × price per share. Exact value 211793.70.

48,806Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Open filing 0002045846-26-000007 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-27Hammes Eric D. Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)10,88527.47
299,010.95

Derived: shares × price per share. Exact value 299010.95.

99,913Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Open filing 0001610493-26-000009 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-24Reis Mischa Officer: SVP, Strategy Bus. Dev.
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,00027.50
220,000

Derived: shares × price per share. Exact value 220000.00.

27,321Direct (D) Yes
F1
  • F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Open filing 0001788632-26-000009 Read from the filing’s XML Dispute this row
2026-08-18 Filed 2026-08-20Keel Paul A Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)179,7300—551,304Direct (D) No
F1
  • F1 Consists of Restricted Stock Units (RSU) that will vest ratably on each anniversary of the date of grant over four years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
Open filing 0001626337-26-000010 Read from the filing’s XML Dispute this row
2026-08-18 Filed 2026-08-20Keel Paul A Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Performance Share Unit — underlying Common Stock (159,900)
Acquired (A)159,9000—159,900Direct (D) No
F2
  • F2 Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved.
Open filing 0001626337-26-000010 Read from the filing’s XML Dispute this row
2026-08-18 Filed 2026-08-20Hammes Eric D. Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Performance Share Unit — underlying Common Stock (47,970)
Acquired (A)47,9700—47,970Direct (D) No
F1
  • F1 Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved.
Open filing 0001610493-26-000007 Read from the filing’s XML Dispute this row
2026-05-25 Filed 2026-05-27Keel Paul A Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)12,81123.43
300,161.73

Derived: shares × price per share. Exact value 300161.73.

371,574Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Open filing 0001626337-26-000005 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21TSINGOS CHRISTINE A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9,3300—59,930Direct (D) No
F1
  • F1 Consists of an annual equity grant of Restricted Stock Units (RSUs) for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Open filing 0001278861-26-000008 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21Pierce James Andrew Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9,3300—18,485Direct (D) No
F1
  • F1 Consists of an annual equity grant of Restricted Stock Units (RSUs) for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Open filing 0001886518-26-000007 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21Carruthers Wendy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9,3300—59,940Direct (D) No
F1
  • F1 Consists of an annual equity grant of Restricted Stock Units (RSUs) for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Open filing 0001563565-26-000003 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21Huennekens R Scott Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,5850—82,105Direct (D) No
F1
  • F1 Consists of an annual equity grant of Restricted Stock Units (RSUs) for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Open filing 0001365493-26-000003 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21Raskas Daniel Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9,3300—54,010Direct (D) No
F1
  • F1 Consists of an annual equity grant of Restricted Stock Units (RSUs) for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Open filing 0001306860-26-000003 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21Jain Vivek Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9,3300—52,945Direct (D) No
F1
  • F1 Consists of an annual equity grant of Restricted Stock Units (RSUs) for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Open filing 0001410442-26-000005 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21GALLAHUE KIERAN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9,3300—54,010Direct (D) No
F1
  • F1 Consists of an annual equity grant of Restricted Stock Units (RSUs) for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
Open filing 0001308428-26-000003 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Kaabi Faez C Officer: Chief Accounting Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)4,96429.59
146,884.76

Derived: shares × price per share. Exact value 146884.76.

45,032Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units (RSUs).
Open filing 0001993528-26-000003 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Kaabi Faez C Officer: Chief Accounting Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)13,5200—58,552Direct (D) No
F2
  • F2 Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
Open filing 0001993528-26-000003 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Acurio Veronica Officer: President, Orthodontics
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,41229.59
41,781.08

Derived: shares × price per share. Exact value 41781.08.

48,911Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units (RSU).
Open filing 0002045846-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Acurio Veronica Officer: President, Orthodontics
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,6050—56,516Direct (D) No
F2
  • F2 Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
Open filing 0002045846-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Acurio Veronica Officer: President, Orthodontics
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Performance Share Unit — underlying Common Stock (13,845)
Acquired (A)13,8450—13,845Direct (D) No
F3
  • F3 Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
Open filing 0002045846-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Acurio Veronica Officer: President, Orthodontics
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (18,020) — exercise price 29.59
Acquired (A)18,0200—18,020Direct (D) No
F4
  • F4 This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.
Open filing 0002045846-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Nilsson Stefan Officer: President, Nobel Biocare
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)18229.59
5,385.38

Derived: shares × price per share. Exact value 5385.38.

54,759Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units (RSU).
Open filing 0002045818-26-000002 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Nilsson Stefan Officer: President, Nobel Biocare
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,6050—62,364Direct (D) No
F2
  • F2 Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
Open filing 0002045818-26-000002 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Nilsson Stefan Officer: President, Nobel Biocare
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Performance Share Unit — underlying Common Stock (13,845)
Acquired (A)13,8450—13,845Direct (D) No
F3
  • F3 Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
Open filing 0002045818-26-000002 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Nilsson Stefan Officer: President, Nobel Biocare
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (18,020) — exercise price 29.59
Acquired (A)18,0200—18,020Direct (D) No
F4
  • F4 This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.
Open filing 0002045818-26-000002 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Nance Mark E Officer: General Counsel
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,36829.59
99,659.12

Derived: shares × price per share. Exact value 99659.12.

68,577Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units (RSU).
Open filing 0001755882-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Nance Mark E Officer: General Counsel
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12,6750—81,252Direct (D) No
F2
  • F2 Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
Open filing 0001755882-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Nance Mark E Officer: General Counsel
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Performance Share Unit — underlying Common Stock (23,070)
Acquired (A)23,0700—23,070Direct (D) No
F3
  • F3 Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
Open filing 0001755882-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Nance Mark E Officer: General Counsel
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (30,040) — exercise price 29.59
Acquired (A)30,0400—30,040Direct (D) No
F4
  • F4 This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.
Open filing 0001755882-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Keel Paul A Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)11,84029.59
350,345.6

Derived: shares × price per share. Exact value 350345.60.

335,715Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units (RSU).
Open filing 0001626337-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Keel Paul A Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)48,6700—384,385Direct (D) No
F2
  • F2 Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
Open filing 0001626337-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Keel Paul A Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Performance Share Unit — underlying Common Stock (132,885)
Acquired (A)132,8850—132,885Direct (D) No
F3
  • F3 Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
Open filing 0001626337-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Keel Paul A Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (115,320) — exercise price 29.59
Acquired (A)115,3200—115,320Direct (D) No
F4
  • F4 This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.
Open filing 0001626337-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Reis Mischa Officer: SVP, Strategy Bus. Dev.
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,97629.59
88,059.84

Derived: shares × price per share. Exact value 88059.84.

29,406Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units (RSU).
Open filing 0001788632-26-000006 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Reis Mischa Officer: SVP, Strategy Bus. Dev.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,9150—35,321Direct (D) No
F2
  • F2 Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
Open filing 0001788632-26-000006 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Reis Mischa Officer: SVP, Strategy Bus. Dev.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Performance Share Unit — underlying Common Stock (10,770)
Acquired (A)10,7700—10,770Direct (D) No
F3
  • F3 Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
Open filing 0001788632-26-000006 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Reis Mischa Officer: SVP, Strategy Bus. Dev.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (14,020) — exercise price 29.59
Acquired (A)14,0200—14,020Direct (D) No
F4
  • F4 This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.
Open filing 0001788632-26-000006 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Hammes Eric D. Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,04529.59
60,511.55

Derived: shares × price per share. Exact value 60511.55.

94,743Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units (RSU).
Open filing 0001610493-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Hammes Eric D. Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)16,0550—110,798Direct (D) No
F2
  • F2 Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
Open filing 0001610493-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Hammes Eric D. Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Performance Share Unit — underlying Common Stock (29,225)
Acquired (A)29,2250—29,225Direct (D) No
F3
  • F3 Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
Open filing 0001610493-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Hammes Eric D. Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (38,040) — exercise price 29.59
Acquired (A)38,0400—38,040Direct (D) No
F4
  • F4 This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.
Open filing 0001610493-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Befidi Robert Officer: President, Diagnostics
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,17729.59
64,417.43

Derived: shares × price per share. Exact value 64417.43.

43,327Direct (D) No
F1
  • F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units (RSU).
Open filing 0002012361-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Befidi Robert Officer: President, Diagnostics
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,6050—50,932Direct (D) No
F2
  • F2 Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
Open filing 0002012361-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Befidi Robert Officer: President, Diagnostics
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Performance Share Unit — underlying Common Stock (13,845)
Acquired (A)13,8450—13,845Direct (D) No
F3
  • F3 Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
Open filing 0002012361-26-000004 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Befidi Robert Officer: President, Diagnostics
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (18,020) — exercise price 29.59
Acquired (A)18,0200—18,020Direct (D) No
F4
  • F4 This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.
Open filing 0002012361-26-000004 Read from the filing’s XML Dispute this row
2026-02-10 Filed 2026-02-11Reis Mischa Officer: SVP, Strategy Bus. Dev.
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)4,04119.04
76,940.64

Derived: shares × price per share. Exact value 76940.64.

36,423Direct (D) Yes
F1
  • F1 These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation.
Open filing 0001788632-26-000004 Read from the filing’s XML Dispute this row
2026-02-10 Filed 2026-02-11Reis Mischa Officer: SVP, Strategy Bus. Dev.
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,04130
121,230

Derived: shares × price per share. Exact value 121230.

32,382Direct (D) Yes
F2
  • F2 The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Open filing 0001788632-26-000004 Read from the filing’s XML Dispute this row
2026-02-10 Filed 2026-02-11Reis Mischa Officer: SVP, Strategy Bus. Dev.
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5,63415.97
89,974.98

Derived: shares × price per share. Exact value 89974.98.

38,016Direct (D) Yes
F1
  • F1 These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation.
Open filing 0001788632-26-000004 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.

Showing 1–50 of 363

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Union Bancaire Privee, UBP SA 500,250,000 PRN96 dollarsNot in the prior quarter’s filings read Open filing 0001716607-26-000011 Filed 2026-11-04 Dispute this row
VICTORY CAPITAL MANAGEMENT INC 91,525,000 PRN87,727,830 dollarsLower by 1,514,000 Prior quarter: 93,039,000Open filing 0001040188-26-000051 Filed 2026-11-10 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager83,906,000 PRN80,692,094 dollarsLower by 10,380,000 Prior quarter: 94,286,000Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
CAMDEN ASSET MANAGEMENT L P /CA 39,990,000 PRN38,308,275 dollarsHigher by 1,500,000 Prior quarter: 38,490,000Open filing 0001104659-26-126495 Filed 2026-11-13 Dispute this row
Wellesley Asset Management 25,445,000 PRN24,372,748 dollarsHigher by 182,000 Prior quarter: 25,263,000Open filing 0001533551-26-000009 Filed 2026-11-12 Dispute this row
BlackRock, Inc. Partly reported under another manager18,888,025 SH443,301,942 dollarsHigher by 450,483 Prior quarter: 18,437,542Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager13,533,000 PRN12,981,125 dollarsHigher by 2,579,000 Prior quarter: 10,954,000Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
STATE STREET CORP Partly reported under another manager12,625,000 PRN12,128,903 dollarsLower by 50,000 Prior quarter: 12,675,000Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
BlackRock, Inc. Partly reported under another manager11,500,000 PRN11,016,425 dollarsLower by 4,320,000 Prior quarter: 15,820,000Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager9,743,352 SH228,673,874 dollarsHigher by 176,403 Prior quarter: 9,566,949Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
ARIEL INVESTMENTS, LLC Partly reported under another manager9,460,307 SH222,033,405 dollarsLower by 357,870 Prior quarter: 9,818,177Open filing 0000936753-26-000057 Filed 2026-11-13 Dispute this row
DeepCurrents Investment Group LLC Partly reported under another manager9,000,000 PRN8,630,487 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002696 Filed 2026-11-13 Dispute this row
CITIGROUP INC Partly reported under another manager8,900,000 PRN8,525,755 dollarsHigher by 6,220,000 Prior quarter: 2,680,000Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
Universal- Beteiligungs- und Servicegesellschaft mbH Partly reported under another manager8,700,000 PRN8,379,545 dollarsHigher by 1,000,000 Prior quarter: 7,700,000Open filing 0002057170-26-000022 Filed 2026-11-10 Dispute this row
Ilex Capital Partners (UK) LLP 7,550,728 SH177,215,586 dollarsHigher by 3,178,019 Prior quarter: 4,372,709Open filing 0001985486-26-000014 Filed 2026-11-13 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 7,419,534 SH174,136,463 dollarsLower by 68,136 Prior quarter: 7,487,670Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 7,123,705 SH167,193,356 dollarsLower by 214,211 Prior quarter: 7,337,916Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager6,736,473 SH158,105,021 dollarsHigher by 1,888,533 Prior quarter: 4,847,940Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager6,672,842 SH156,611,678 dollarsHigher by 236,799 Prior quarter: 6,436,043Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
INCOME RESEARCH MANAGEMENT 6,490,000 SH6,217,072 dollarsLower by 855,000 Prior quarter: 7,345,000Open filing 0001214659-26-013106 Filed 2026-10-21 Dispute this row
Calamos Advisors LLC 5,546,000 PRN5,329,318 dollarsHigher by 11,000 Prior quarter: 5,535,000Open filing 0001316507-26-000004 Filed 2026-11-02 Dispute this row
CONNING INC. 5,350,000 PRN5,126,210 dollarsUnchanged Prior quarter: 5,350,000Open filing 0000801051-26-000004 Filed 2026-10-27 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager5,305,630 SH124,523,184 dollarsHigher by 2,253,111 Prior quarter: 3,052,519Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
STATE STREET CORP Partly reported under another manager5,275,293 SH123,811,127 dollarsLower by 53,982 Prior quarter: 5,329,275Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager5,031,000 PRN4,845,685 dollarsHigher by 3,079,000 Prior quarter: 1,952,000Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
SSI INVESTMENT MANAGEMENT LLC 5,006,000 PRN4,795,480 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-004930 Filed 2026-11-10 Dispute this row
Quantinno Capital Management LP 4,470,689 SH104,927,071 dollarsHigher by 275,803 Prior quarter: 4,194,886Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row
NEUBERGER BERMAN GROUP LLC 4,445,998 SH104,347,573 dollarsHigher by 569,251 Prior quarter: 3,876,747Open filing 0001465109-26-000128 Filed 2026-11-13 Dispute this row
Thrivent Financial for Lutherans Partly reported under another manager3,625,000 PRN3,480 dollarsLower by 1,705,000 Prior quarter: 5,330,000Open filing 0001193125-26-449292 Filed 2026-11-05 Dispute this row
FULLER THALER ASSET MANAGEMENT, INC. 3,319,945 SH77,919,099 dollarsLower by 322,152 Prior quarter: 3,642,097Open filing 0001420506-26-002692 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager3,098,967 SH72,750,752 dollarsLower by 51,541 Prior quarter: 3,150,508Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Partly reported under another manager3,010,886 SH72,009,583 dollarsHigher by 97,042 Prior quarter: 2,913,844Open filing 0000912938-26-001073 Filed 2026-11-12 Dispute this row
MORGAN STANLEY Partly reported under another manager2,991,000 PRN2,865,229 dollarsUnchanged Prior quarter: 2,991,000Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager2,888,960 SH67,803,891 dollarsHigher by 768,829 Prior quarter: 2,120,131Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager2,699,184 SH63,181,303 dollarsLower by 605,762 Prior quarter: 3,304,946Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager2,483,543 SH67,527,535 dollarsLower by 2,326,497 Prior quarter: 4,810,040Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
VICTORY CAPITAL MANAGEMENT INC 2,438,770 SH57,237,932 dollarsLower by 2,055,576 Prior quarter: 4,494,346Open filing 0001040188-26-000051 Filed 2026-11-10 Dispute this row
LOS ANGELES CAPITAL MANAGEMENT LLC 2,033,640 SH47,729,530 dollarsHigher by 1,322,667 Prior quarter: 710,973Open filing 0001177206-26-000010 Filed 2026-11-12 Dispute this row
Qube Research Technologies Ltd 1,731,009 SH40,626,781 dollarsNot in the prior quarter’s filings read Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager1,682,635 SH39,491,439 dollarsHigher by 370,732 Prior quarter: 1,311,903Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager1,619,765 SH38,015,885 dollarsHigher by 99,200 Prior quarter: 1,520,565Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Boston Partners Partly reported under another manager1,456,067 SH34,144,296 dollarsHigher by 454,324 Prior quarter: 1,001,743Open filing 0001386060-26-000054 Filed 2026-11-10 Dispute this row
Tweedy, Browne Co LLC 1,416,184 SH33,237,838 dollarsLower by 19,064 Prior quarter: 1,435,248Open filing 0000732905-26-000001 Filed 2026-11-04 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager1,369,708 SH32,147,046 dollarsLower by 46,455 Prior quarter: 1,416,163Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Clarkston Capital Partners, LLC 1,355,250 SH31,807,718 dollarsLower by 118,800 Prior quarter: 1,474,050Open filing 0001172661-26-004920 Filed 2026-11-10 Dispute this row
ROYCE ASSOCIATES LP 1,283,467 SH30,122,970 dollarsHigher by 12,750 Prior quarter: 1,270,717Open filing 0000906304-26-000218 Filed 2026-11-09 Dispute this row
Paradice Investment Management LLC Partly reported under another manager1,280,654 SH30,056,949 dollarsLower by 940 Prior quarter: 1,281,594Open filing 0001172661-26-004586 Filed 2026-10-19 Dispute this row
PZENA INVESTMENT MANAGEMENT LLC 1,136,001 SH26,661,943 dollarsLower by 21,272 Prior quarter: 1,157,273Open filing 0001027796-26-000065 Filed 2026-10-30 Dispute this row
SHENKMAN CAPITAL MANAGEMENT INC 1,126,000 PRN1,085,388 dollarsUnchanged Prior quarter: 1,126,000Open filing 0001275228-26-000007 Filed 2026-11-10 Dispute this row
VANGUARD FIDUCIARY TRUST CO 1,017,649 SH23,884,222 dollarsLower by 14,081 Prior quarter: 1,031,730Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Weiss Asset Management LP 77,224,000 PRN
  • Point72 Asset Management, L.P. 17,250,000 PRN
  • BANK OF AMERICA CORP /DE/ 10,508,000 PRN
  • OAKTREE CAPITAL MANAGEMENT LP 10,206,000 PRN
  • Gates Capital Management, Inc. 5,552,383 SH
  • ALLIANCEBERNSTEIN L.P. 5,213,644 SH
  • DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 4,700,000 PRN
  • PALISADE CAPITAL MANAGEMENT, LP 4,657,000 PRN
  • AQR CAPITAL MANAGEMENT LLC 4,023,691 SH
  • STATE OF WISCONSIN INVESTMENT BOARD 4,023,129 SH
  • HARRIS ASSOCIATES L P 2,756,781 SH
  • BANK OF AMERICA CORP /DE/ 2,743,403 SH
  • Ares Systematic Credit Ltd 2,400,000 PRN
  • DEERFIELD MANAGEMENT COMPANY, L.P. 2,210,100 SH
  • NORGES BANK 2,051,894 SH
  • Sixth Street Partners Management Company, L.P. 1,969,683 SH
  • CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,969,683 SH
  • Gotham Asset Management, LLC 1,765,134 SH
  • WELLINGTON MANAGEMENT GROUP LLP 1,686,415 SH
  • NORTHERN TRUST CORP 1,653,871 SH
  • Point72 Asset Management, L.P. 1,563,395 SH
  • FRONTIER CAPITAL MANAGEMENT CO LLC 1,388,673 SH
  • GOLDMAN SACHS GROUP INC 1,364,347 SH
  • MILLENNIUM MANAGEMENT LLC 1,147,047 SH
  • OBERWEIS ASSET MANAGEMENT INC/ 1,120,782 SH
  • PRUDENTIAL FINANCIAL INC 1,044,240 SH
  • Defilade Capital Management, L.P. 726,108 SH
  • Corient Private Wealth LP 703,864 SH
  • ArrowMark Colorado Holdings LLC 663,643 SH
  • KIM, LLC 658,000 PRN
  • ALGERT GLOBAL LLC 657,381 SH
  • Integral Health Asset Management, LLC 600,000 SH
  • Parkman Healthcare Partners LLC 553,916 SH
  • PALISADE CAPITAL MANAGEMENT, LP 534,175 SH
  • WELLS FARGO COMPANY/MN 492,000 PRN
  • Jupiter Topco LLC 480,349 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 452,072 SH
  • UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 435,315 SH
  • AMERIPRISE FINANCIAL INC 358,972 SH
  • California Public Employees Retirement System 349,098 SH
  • ExodusPoint Capital Management, LP 336,250 SH
  • Capricorn Fund Managers Ltd 319,028 SH
  • Aristotle Capital Boston, LLC 317,799 SH
  • DANSKE BANK A/S 261,489 SH
  • Trexquant Investment LP 241,462 SH
  • D. E. Shaw Co., Inc. 228,766 SH
  • Legal General Group Plc 227,212 SH
  • JANE STREET GROUP, LLC 213,633 SH
  • Jain Global LLC 198,747 SH
  • WINTON GROUP Ltd 192,055 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
AQR Capital Management, LLC Common stock, $0.01 par value5.298,502,40509/30/2026 Filed 2026-11-13SCHEDULE 13GOpen filing 0001167557-26-000275 Dispute this row
AQR Capital Management Holdings, LLC Common stock, $0.01 par value5.298,502,40509/30/2026 Filed 2026-11-13SCHEDULE 13GOpen filing 0001167557-26-000275 Dispute this row
Morgan Stanley Common Stock4.47,094,58403/31/2026 Filed 2026-05-11SCHEDULE 13G/AAmendment 7Open filing 0000895421-26-000139 Dispute this row
Atlanta Capital Management Company, LLC Common Stock3.75,975,56103/31/2026 Filed 2026-05-11SCHEDULE 13G/AAmendment 7Open filing 0000895421-26-000139 Dispute this row
Vanguard Capital Management Common Stock5.238,574,55703/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100119-26-000393 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 1Open filing 0000102909-26-001259 Dispute this row
Franklin Mutual Advisers, LLC Common stock, $0.01 par value4.857,985,856.0012/31/2025 Filed 2026-01-29SCHEDULE 13G/AAmendment 1Open filing 0001023875-26-000001 Dispute this row
Morgan Stanley Common Stock6.110,129,21209/30/2025 Filed 2025-11-07SCHEDULE 13G/AAmendment 6Open filing 0000895421-25-000543 Dispute this row
Atlanta Capital Management Company, LLC Common Stock5.49,057,77009/30/2025 Filed 2025-11-07SCHEDULE 13G/AAmendment 6Open filing 0000895421-25-000543 Dispute this row
HARRIS ASSOCIATES L P Common Stock, $0.01 par value4.67,812,256.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001415889-25-021856 Dispute this row
Harris Associates, Inc. Common Stock, $0.01 par value4.67,812,256.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001415889-25-021856 Dispute this row
Franklin Mutual Advisers, LLC Common stock, $0.01 par value5.38,953,400.0006/30/2025 Filed 2025-08-05SCHEDULE 13GOpen filing 0001023875-25-000020 Dispute this row
Dimensional Fund Advisors LP Common Stock5.49,170,511.0006/30/2025 Filed 2025-07-15SCHEDULE 13GOpen filing 0000354204-25-001073 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,102,727 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024195,705
2025235,520
2026254,737

Filings made before the SEC required XML are listed, not extracted.

Back to ENVISTA HOLDINGS CORPORATION